Stone House Investment Management’s AbbVie ABBV Stock Holding History

Stone House Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115K	Buy	530 +39	+8%	+$8.65K	0.02%	109
2025 Q4	$112K	Buy	491 +3	+0.6%	+$683	0.02%	112
2025 Q3	$113K	Buy	488 +5	+1%	+$1.02K	0.02%	108
2025 Q2	$89.7K	Buy	483 +220	+84%	+$40.9K	0.02%	113
2025 Q1	$55.2K	Buy	+263	New	+$51.1K	0.01%	138
2024 Q4	–	Sell	-277	Closed	-$54.8K	–	52
2024 Q3	$54.8K	Hold	277	–	–	0.01%	112
2024 Q2	$47.6K	Hold	277	–	–	0.01%	127
2024 Q1	$50.5K	Buy	277 +191	+222%	+$32.9K	0.01%	131
2023 Q4	$13.3K	Buy	86 +1	+1%	+$146	﹤0.01%	146
2023 Q3	$12.7K	Hold	85	–	–	﹤0.01%	148
2023 Q2	$11.4K	Sell	85 -149	-64%	-$21.9K	﹤0.01%	151
2023 Q1	$37.3K	Buy	+234	New	+$35.8K	0.01%	99
2019 Q2	–	Sell	-35	Closed	-$3K	–	38
2019 Q1	$3K	Buy	+35	New	+$2.86K	﹤0.01%	196

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stone House Investment Management's ABBV Position: Q1 2026 in Review

Stone House Investment Management increased its AbbVie (ABBV) stake by 7.9% in Q1 2026, buying an estimated $8.65K and bringing the position to 530 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #109.

Stone House Investment Management first reported a position in ABBV in Q1 2019 and has held it in 13 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Stone House Investment Management held 530 shares of AbbVie worth $115K as of Q1 2026.
Stone House Investment Management bought 39 AbbVie shares in Q1 2026, an estimated $8.65K.
AbbVie made up 0.02% of Stone House Investment Management's portfolio in Q1 2026, its #109 holding.
Stone House Investment Management first reported a position in AbbVie in Q1 2019 and has held it in 13 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.